Dec 20 (Reuters) - Anatara Lifesciences Ltd (ANR) :
- UPDATES ON PROTOCOL FOR ITS CLINICAL TRIAL IN IRRITABLE BOWEL SYNDROME (IBS) FOR ITS GARP DIETARY SUPPLEMENT.
- MET PROJECTED MILESTONE TO FINALISE DRAFT PROTOCOL FOR HUMAN CLINICAL TRIAL FOR GASTROINTESTINAL REPROGRAMMING DIETARY SUPPLEMENT
News: ANR Anatara Lifesciences Updates On Protocol For Its Clinical Trial In IBS
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
-0.002(15.4%) |
Mkt cap ! $2.349M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.1¢ | $41.30K | 3.398M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2003147 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 1354471 | 3 |
View Market Depth
| Last trade - 16.10pm 09/09/2025 (20 minute delay) ? |
| ANR (ASX) Chart |